Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
Open Access
- 12 June 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11, 554
Abstract
Myasthenia gravis (MG) with onset below 50 years, thymic hyperplasia and acetylcholine receptor (AChR) antibodies is more common in females than in males. For a relatively large group of MG patients, pregnancy represents therefore an important question. The muscle weakness, the circulating autoantibodies, the hyperplastic thymus, the MG drug treatment, and any autoimmune comorbidity may all influence both mother and child health during pregnancy and also during breastfeeding in the postpartum period. Mother's MG remains stable in most patients during pregnancy. Pyridostigmine, prednisolone, and azathioprine are regarded as safe during pregnancy. Mycophenolate, methotrexate and cyclophosphamide are teratogenic and should not be used by women with the potential to become pregnant. Rituximab should not be given during the last few months before conception and not during pregnancy. Intravenous immunoglobulin and plasma exchange can be used for exacerbations or when need for intensified therapy. Pregnancies in MG women are usually without complications. Their fertility is near normal. Vaginal delivery is recommended. MG patients have an increased rate of Cesarean section, partly due to their muscle weakness and to avoid exhaustion, partly as a precaution that is often unnecessary. Around 10% of the newborn develop neonatal myasthenia during the first few days after birth. This is transient and usually mild with some sucking and swallowing difficulties. In rare cases, transplacental transfer of AChR antibodies leads to permanent muscle weakness in the child, and arthrogryposis with joint contractures. Repeated spontaneous abortions have been described due to AChR antibodies. MG women should always give birth at hospitals with experience in newborn intensive care. MG does not represent a reason for not having children, and the patients should be supported in their wish of becoming pregnant.Keywords
This publication has 49 references indexed in Scilit:
- Myasthenia Gravis and PregnancyClinical Obstetrics and Gynecology, 2013
- Acquired myasthenia gravis in childhoodCurrent Opinion in Neurology, 2010
- No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population‐based studyEuropean Journal of Neurology, 2009
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- ISOLATED FACIAL AND BULBAR PARESIS: A PERSISTENT MANIFESTATION OF NEONATAL MYASTHENIA GRAVISNeurology, 2008
- Can neonatal myasthenia gravis be predicted?Journal of Perinatal Medicine, 2008
- Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising careEuropean Journal of Neurology, 2007
- Myasthénie auto-immune et grossesse : évolution clinique, accouchement et post-partumRevue Neurologique, 2006
- Asymptomatic myasthenia gravis influences pregnancy and birthEuropean Journal of Neurology, 2004
- Evolution of Maternofetal Transport of Immunoglobulins During Human PregnancyAmerican Journal of Reproductive Immunology, 1996